(Q44264038)

English

Macrovascular and microvascular outcomes after beginning of insulin versus additional oral glucose-lowering therapy in people with type 2 diabetes: an observational study

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Macrovascular and microvascular outcomes after beginning of insulin versus additional oral glucose-lowering therapy in people with type 2 diabetes: an observational study (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

0 references

0 references

type 2 diabetes

1 reference

based on heuristic

inferred from title

author name string

Gillian C Hall

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Alex D McMahon

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Dawn Carroll

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Philip D Home

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

publication date

23 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Pharmacoepidemiology and Drug Safety

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

305-313

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people

1 reference

https://api.crossref.org/works/10.1002%2FPDS.2345

21 January 2018

10-year follow-up of intensive glucose control in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FPDS.2345

21 January 2018

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1002%2FPDS.2345

21 January 2018

Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

https://api.crossref.org/works/10.1002%2FPDS.2345

21 January 2018

Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57).

1 reference

https://api.crossref.org/works/10.1002%2FPDS.2345

21 January 2018

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1002%2FPDS.2345

21 January 2018

The joint effects of different types of glucose-lowering treatment and duration of diabetes on total and cardiovascular mortality among subjects with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1002%2FPDS.2345

21 January 2018

Association between serious ischemic cardiac outcomes and medications used to treat diabetes

1 reference

https://api.crossref.org/works/10.1002%2FPDS.2345

21 January 2018

Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research

1 reference

https://api.crossref.org/works/10.1002%2FPDS.2345

21 January 2018

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1002%2FPDS.2345

21 January 2018

Prevalence of inadequate glycemic control among patients with type 2 diabetes in the United Kingdom general practice research database: A series of retrospective analyses of data from 1998 through 2002.

1 reference

https://api.crossref.org/works/10.1002%2FPDS.2345

21 January 2018

Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients

1 reference

https://api.crossref.org/works/10.1002%2FPDS.2345

21 January 2018

Insulin-based versus triple oral therapy for newly diagnosed type 2 diabetes: which is better?

1 reference

https://api.crossref.org/works/10.1002%2FPDS.2345

21 January 2018

Validation of death and suicide recording on the THIN UK primary care database

1 reference

https://api.crossref.org/works/10.1002%2FPDS.2345

21 January 2018

Achievement of metabolic targets for diabetes by English primary care practices under a new system of incentives

1 reference

https://api.crossref.org/works/10.1002%2FPDS.2345

21 January 2018

Identifiers

10.1002/PDS.2345

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44264038&oldid=2108988062"